Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of AcquisitionGlobeNewsWire • 12/05/25
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA RoyaltyGlobeNewsWire • 11/26/25
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA RoyaltyGlobeNewsWire • 10/24/25
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General MeetingGlobeNewsWire • 09/23/25
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Mural Oncology plc (NASDAQ: MURA)PRNewsWire • 08/27/25
MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to ShareholdersBusiness Wire • 08/20/25
Mural Oncology Announces Second Quarter Financial Results and Provides Business UpdateGlobeNewsWire • 08/04/25
MURA Soars as it Explores Strategic Options Post Cancer Study FailuresZacks Investment Research • 04/16/25
Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian CancerGlobeNewsWire • 03/25/25
Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical MilestonesGlobeNewsWire • 03/11/25
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 12/03/24
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of CancerGlobeNewsWire • 11/20/24
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)GlobeNewsWire • 11/07/24
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)GlobeNewsWire • 10/07/24
Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo MinegishiGlobeNewsWire • 09/23/24